Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

492 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
From conventional to living guidelines - faster updates for better informed guidance? A scoping review.
Pielenz C, Schneider M, Salveridou-Hof E, Flick M, Gaigl G, Khorikian-Ghazari N, Güler D, Halms T, Kapfhammer A, Lorenz C, Röh A, Wagner E, Falkai P, Leucht S, Gaebel W, Hasan A. Pielenz C, et al. Among authors: leucht s. Z Evid Fortbild Qual Gesundhwes. 2022 Nov;174:20-31. doi: 10.1016/j.zefq.2022.07.004. Epub 2022 Aug 28. Z Evid Fortbild Qual Gesundhwes. 2022. PMID: 36041983 Free article. Review.
A randomized double-blind controlled trial to assess the benefits of amisulpride and olanzapine combination treatment versus each monotherapy in acutely ill schizophrenia patients (COMBINE): methods and design.
Schmidt-Kraepelin C, Feyerabend S, Engelke C, Riesbeck M, Meisenzahl-Lechner E, Gaebel W, Verde PE, Kolbe H, Correll CU, Leucht S, Heres S, Kluge M, Makiol C, Neff A, Lange C, Englisch S, Zink M, Langguth B, Poeppl T, Reske D, Gouzoulis-Mayfrank E, Gründer G, Hasan A, Brockhaus-Dumke A, Jäger M, Baumgärtner J, Wobrock T, Cordes J. Schmidt-Kraepelin C, et al. Among authors: leucht s. Eur Arch Psychiatry Clin Neurosci. 2020 Feb;270(1):83-94. doi: 10.1007/s00406-019-01063-4. Epub 2019 Sep 5. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31486890
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial.
Huhn M, Leucht C, Rothe P, Dold M, Heres S, Bornschein S, Schneider-Axmann T, Hasan A, Leucht S. Huhn M, et al. Among authors: leucht c, leucht s. Eur Arch Psychiatry Clin Neurosci. 2021 Mar;271(2):293-302. doi: 10.1007/s00406-020-01109-y. Epub 2020 Feb 15. Eur Arch Psychiatry Clin Neurosci. 2021. PMID: 32062728 Free PMC article. Clinical Trial.
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial.
Hasan A, Roeh A, Leucht S, Langguth B, Hansbauer M, Oviedo-Salcedo T, Kirchner SK, Papazova I, Löhrs L, Wagner E, Maurus I, Strube W, Rossner MJ, Wehr MC, Bauer I, Heres S, Leucht C, Kreuzer PM, Zimmermann S, Schneider-Axmann T, Görlitz T, Karch S, Egert-Schwender S, Schossow B, Rothe P, Falkai P. Hasan A, et al. Among authors: leucht s, leucht c. Contemp Clin Trials Commun. 2020 Jan 28;17:100537. doi: 10.1016/j.conctc.2020.100537. eCollection 2020 Mar. Contemp Clin Trials Commun. 2020. PMID: 32072071 Free PMC article.
Metabolic side effects of antipsychotic drugs in individuals with schizophrenia during medium- to long-term treatment: protocol for a systematic review and network meta-analysis of randomized controlled trials.
Schneider-Thoma J, Kapfhammer A, Wang D, Bighelli I, Siafis S, Wu H, Hansen WP, Davis JM, Salanti G, Leucht S. Schneider-Thoma J, et al. Among authors: leucht s. Syst Rev. 2021 Aug 2;10(1):214. doi: 10.1186/s13643-021-01760-z. Syst Rev. 2021. PMID: 34340713 Free PMC article.
492 results